€
5.60
May 14
Business Description
Cipher Pharmaceuticals Inc
NAICS : 325412
SIC : 3741
ISIN : CA17253X1050
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 112.96 | |||||
Equity-to-Asset | 0.94 | |||||
Debt-to-EBITDA | 0.03 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 19.67 | |||||
Beneish M-Score | -2.43 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 3.4 | |||||
3-Year EBITDA Growth Rate | 16.4 | |||||
3-Year EPS without NRI Growth Rate | 41.2 | |||||
3-Year FCF Growth Rate | 17.8 | |||||
3-Year Book Growth Rate | 42.7 | |||||
Future 3-5Y Total Revenue Growth Rate | 0.9 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 21.56 | |||||
9-Day RSI | 34.08 | |||||
14-Day RSI | 41.75 | |||||
6-1 Month Momentum % | 69.89 | |||||
12-1 Month Momentum % | 165.09 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 9.19 | |||||
Quick Ratio | 8.62 | |||||
Cash Ratio | 7.58 | |||||
Days Inventory | 231.72 | |||||
Days Sales Outstanding | 103.34 | |||||
Days Payable | 439.93 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 3.8 | |||||
Shareholder Yield % | 3.57 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 80.77 | |||||
Operating Margin % | 47.42 | |||||
Net Margin % | 96.26 | |||||
FCF Margin % | 62.33 | |||||
ROE % | 28.3 | |||||
ROA % | 24.94 | |||||
ROIC % | 42.81 | |||||
ROC (Joel Greenblatt) % | 905.42 | |||||
ROCE % | 13.89 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 8.3 | |||||
Forward PE Ratio | 11.06 | |||||
PE Ratio without NRI | 8.56 | |||||
Shiller PE Ratio | 39.6 | |||||
Price-to-Owner-Earnings | 12.55 | |||||
PEG Ratio | 0.42 | |||||
PS Ratio | 7.87 | |||||
PB Ratio | 1.96 | |||||
Price-to-Tangible-Book | 2.37 | |||||
Price-to-Free-Cash-Flow | 10.41 | |||||
Price-to-Operating-Cash-Flow | 10.41 | |||||
EV-to-EBIT | 11.27 | |||||
EV-to-EBITDA | 10.04 | |||||
EV-to-Revenue | 5.34 | |||||
EV-to-Forward-Revenue | 5.13 | |||||
EV-to-FCF | 7.34 | |||||
Price-to-Projected-FCF | 0.91 | |||||
Price-to-Median-PS-Value | 2.67 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.45 | |||||
Price-to-Graham-Number | 0.93 | |||||
Price-to-Net-Current-Asset-Value | 3.5 | |||||
Price-to-Net-Cash | 4.38 | |||||
Earnings Yield (Greenblatt) % | 8.88 | |||||
FCF Yield % | 10.33 | |||||
Forward Rate of Return (Yacktman) % | 24.48 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Cipher Pharmaceuticals Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 20.477 | ||
EPS (TTM) (€) | 0.823 | ||
Beta | 0.42 | ||
Volatility % | 53.82 | ||
14-Day RSI | 41.75 | ||
14-Day ATR (€) | 0.151414 | ||
20-Day SMA (€) | 5.9325 | ||
12-1 Month Momentum % | 165.09 | ||
52-Week Range (€) | 2.28 - 6.65 | ||
Shares Outstanding (Mil) | 24.11 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Cipher Pharmaceuticals Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Cipher Pharmaceuticals Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Cipher Pharmaceuticals Inc Frequently Asked Questions
What is Cipher Pharmaceuticals Inc(FRA:PHE)'s stock price today?
When is next earnings date of Cipher Pharmaceuticals Inc(FRA:PHE)?
Does Cipher Pharmaceuticals Inc(FRA:PHE) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |